Citation: | Qiwang Liu, Xiaoshuang Wu, Yaozhen Chen, Zhixin Liu, Wenting Wang, Qunxing An, Xingbin Hu. The inflammation mediated by mesenchymal stem cells enhances blood group antigen-antibody responses via IL-1β[J]. Blood&Genomics, 2023, 7(1): 67-70. doi: 10.46701/BG.2023012022024 |
[1] |
Gibb DR, Calabro S, Liu D, et al. The Nlrp3 inflammasome does not regulate alloimmunization to transfused red blood cells in mice[J]. EBioMedicine, 2016, 9: 77−86. doi: 10.1016/j.ebiom.2016.06.008
|
[2] |
Elayeb R, Tamagne M, Bierling P, et al. Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion[J]. Haematologica, 2016, 101(2): 209−218. doi: 10.3324/haematol.2015.134171
|
[3] |
Yi T, Li J, Chen H, et al. Splenic dendritic cells survey red blood cells for missing self-CD47 to trigger adaptive immune responses[J]. Immunity, 2015, 43(4): 764−775. doi: 10.1016/j.immuni.2015.08.021
|
[4] |
Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation[J]. Cell Stem Cell, 2013, 13: 392−402. doi: 10.1016/j.stem.2013.09.006
|
[5] |
Chen Y, Qin X, An Q, et al. Mesenchymal stromal cells directly promote inflammation by canonical NLRP3 and non-canonical caspase-11 inflammasomes[J]. EBioMedicine, 2018, 32: 31−42. doi: 10.1016/j.ebiom.2018.05.023
|
[6] |
Chen Y, Zhang J, Gu S, et al. Mesenchymal stromal cells can be applied to red blood cells storage as a kind of cellular additive[J]. Biosci Rep, 2017, 37(5): BSR20170676. doi: 10.1042/BSR20170676
|
[7] |
Hu X, Garcia M, Weng L, et al. Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche[J]. Nat Commun, 2016, 7: 13095. doi: 10.1038/ncomms13095
|
[8] |
Zhang K, Jiang Y, Wang B, et al. Mesenchymal stem cell therapy: a potential treatment targeting pathological manifestations of traumatic brain injury[J]. Oxid Med Cell Longev, 2022, 2022: 4645021. doi: 10.1155/2022/4645021
|